期刊文献+

自分泌运动因子及其受体在乳腺癌中的表达 被引量:1

Expression of atuocrine motility factor and its receptor in breast carcinoma
下载PDF
导出
摘要 目的 了解自分泌运动因子 (autocrinemotilityfactor,AMF)及其受体 (autocrinemotilityfactorreceptor,AMFR)在乳腺癌组织中的表达及其与乳腺癌临床病理特征之间的关系。方法 应用免疫组化SABC方法研究 2 5例正常乳腺组织、2 3例乳腺上皮增生组织、71例乳腺癌组织中AMF、AMFR的表达。结果 AMF与AMFR阳性结果完全一致。正常乳腺组织、乳腺上皮增生组织AMF、AMFR阳性率均低于癌组织 (P <0 .0 5 )。 71例原发性乳腺癌组织中有 4 5例 (6 3% )阳性。浸润性导管癌AMF、AMFR水平明显高于导管内癌 (P =0 .0 0 1)。AMF、AMFR高表达与乳腺癌组织学分级、TNM分期有关 (P <0 .0 5 ) ,与年龄、肿块大小、淋巴结是否转移无关 (P >0 .0 5 )。结论 AMF、AMFR表达水平高与乳腺癌的进展有关 ,具有判断预后的价值。 Objective To investigate the expression of autocrine motility factor(AMF)and its receptor (AMFR) in the breast carcinoma and whether there is correlation between AMF、 AMFR expression and clinicopathologic features of breast carcinoma. Methods By using immunohistochemical SABC method,the expressions of AMF、AMFR were determined in 25 cases of normal breast epithelium、 23 cases of epithelial hyperplasia and 71 cases of primary breast cancer. Results The positive expressions of AMF and AMFR in breast tissues were almost identical.The expression levels of AMF and AMFR in normal breast epithelium and epithelial hyperplasia were lower than that in breast carcinomas( P <0.05). Positive expressions of AMF or AMFR were both 63% in 71 cases of primary breast cancer. The expression level of AMF or AMFR in invasive ductal carcinomas was higher than that in ductal carcinomas in situ( P <0.05). The expressions of AMF or AMFR correlated positively with histologic grade and tumor stage( P <0.05),but not with age,tumor size and lymph node metastasis( P >0.05). Conclusion AMF and AMFR may contibute to tumor progression,and can serve as an useful prognostic marker in breast carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2004年第2期152-154,共3页 Tumor
基金 安徽省高等学校青年教师科研资助计划项目 (编号 :2 0 0 3jq12 5 )
关键词 自分泌运动因子 乳腺癌 自分泌运动因子受体 预后 肿瘤转移 Breast neoplasms Autocrine motility factor Autocrine motility factor receptor Neoplasm metastasis
  • 相关文献

参考文献10

  • 1Watanabe H, Carmi P, Hogan V, et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor[J]. J Biol Chem, 1991,266(20): 13442
  • 2Takanami I, Takeuchi K, Watanabe H,et al. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer[J]. Int J Cancer,2001,95(6) : 384
  • 3Kawanishi K, Doki Y, Shiozaki H, et al. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers[J]. Am J Clin Pathol, 2000, 113 (2):266
  • 4Nakamori S, Watanabe H, Kameyama M, et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence[J]. Cancer, 1994, 74 (7) :1855
  • 5Silletti S,Watanabe H, Hogan V,et al. Purification of B16-F1 melanoma autocrine motility factor and its receptor[J]. Cancer Res,1991,51(13) :3507
  • 6Benlimame N, Le PU, Nabi IR. Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum[J]. Mol Biol Cell, 1998,9(7): 1773
  • 7Silletti S, Yao JP, Pienta KJ,et al. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells[J]. Int J Cancer, 1995,63(1): 100
  • 8Yelian FD, Liu A, Todt JC,et al. Expression and function of autocrine motility factor receptor in human choriocarcinoma[J]. Gynecol Oncol, 1996,62(2): 159
  • 9Tsutsumi S, Yanagawa T, Shimura T, et al. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling[J]. J Biol Chem. 2003,278(34) :32165
  • 10Timar J, Toth S, Tovari J, et al. Autocrine motility factor(neuroleukin, phosphohexose isomerase)induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events [J]. Clin Exp Metastasis, 1999,17 (10): 8

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部